Pravastatin increases the expression of the tissue inhibitor of matrix metalloproteinase-1 and the oncogene Bax in human aortic abdominal aneurysms

Canadian Journal of Physiology and Pharmacology

Volumn 86, Issue 7, 2008, Pages 431-437

  Mateos Cáceres, Petra J ^a   López Farré, Antonio J ^a   Morata, Pilar C ^a   Ramos Mozo, Priscila ^a   Macaya, Carlos ^a   Serrano, Francisco J ^a   Moñux, Guillermo ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Aortic abdominal aneurysms; Apoptosis; Matrix metalloproteinases; Pravastatin; Tissue inhibitor of metalloproteinases

Indexed keywords

INTERSTITIAL COLLAGENASE; PRAVASTATIN; PROTEIN BAX; PROTEIN BCL 2; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; APOPTOSIS; ARTICLE; BAX GENE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; ENZYME SYNTHESIS; EXPLANT; FEMALE; HUMAN; HUMAN TISSUE; MALE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

AGED; AORTIC ANEURYSM, ABDOMINAL; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PRAVASTATIN; PROTO-ONCOGENE PROTEINS C-BCL-2; STIMULATION, CHEMICAL; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 46749147923     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y08-060     Document Type: Article

References (40)

1. Akahane, T., Akahane, M., Shah, A., and Thorgeirsson, U.P. 2004. TIMP-1 stimulates proliferation of human aortic smooth muscle cells and Ras effector pathways. Biochem. Biophys. Res. Commun. 324: 440-445. doi:10.1016/j.bbrc.2004.09.063. PMID:15465038.
2. Annabi, B., Shédid, D., Ghosn, P., Kenigsberg, R.L., Desrosiers, R.R., Bojanowski, M.W., et al. 2002. Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms. J. Vasc. Surg. 35: 539-546. doi:10.1067/mva.2002. 121124. PMID:11877705.
3. Bartoli, M.A., Parodi, F.E., Chu, J., Pagano, M.B., Mao, D., Baxter, B.T., et al. 2006. Localized administration of doxycycline suppresses aortic dilatation in an experimental mouse model of abdominal aortic aneurysm. Ann. Vasc. Surg. 20: 228-236. doi:10.1007/s10016-006-9017-z. PMID:16572291.
4. Brophy, C.M., Marks, W.H., Reilly, J.M., and Tilson, M.D. 1991. Decreased tissue inhibitor of metalloproteinases (TIMP) in abdominal aortic aneurysm tissue: a preliminary report. J. Surg. Res. 50: 653-657. doi:10.1016/0022-4804(91)90058-T. PMID:2051779.
5. Crespo, M.J., and Quidgley, J.A. 2006. Statins decrease serotonin-induced contractions in coronary arteries of swine in vitro. Pharmacology, 76: 141-147. doi:10.1159/000091045. PMID:16428899.
6. Demierre, M.F., Higgins, P.D., Gruber, S.B., Hawk, E., and Lippman, S.M. 2005. Statins and cancer prevention. Nat. Rev. Cancer, 5: 930-942. doi:10.1038/nrc1751. PMID:16341084.
7. Elmore, J.R., Keister, B.F., Franklin, D.P., Youkey, J.R., and Carey, D.J. 1998. Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms. Ann. Vasc. Surg. 12: 221-228. doi:10.1007/ s100169900144. PMID:9588507.
8. Eskandari, M.K., Vijungco, J.D., Flores, A., Borensztajn, J., Shively, V., and Pearce, W.H. 2005. Enhanced abdominal aortic aneurysm in TIMP-1-deficient mice. J. Surg. Res. 123: 289-293. doi:10.1016/j.jss. 2004.07.247. PMID:15680392.
9. Fukui, D., Miyagawa, S., Soeda, J., Tanaka, K., Urayama, H., and Kawasaki, S. 2003. Overexpression of transforming growth factor beta 1 in smooth muscle cells of human abdominal aortic aneurysm. Eur. J. Vasc. Endovasc. Surg. 25: 540-545. doi:10. 1053/ejvs.2002.1857. PMID:12787696.
10. Galis, Z.S., and Khatri, J.J. 2002. Matrix metalloproteinases in vascular remodelling and atherogenesis: The good, the bad and the ugly. Circ. Res. 90: 251-262. PMID:11861412.
11. Gattorno, M., Gerloni, V., Morando, A., Comanducci, F., Buoncompagni, A., Picco, P., et al. 2002. Synovial membrane expression of matrix metalloproteinases and tissue inhibitor 1 in juvenile idiopathic arthritides. J. Rheumatol. 29: 1774-1779. PMID:12180743.
12. Gomez, D.E., Alonso, D.F., Yoshiji, H., and Thorgeirsson, U.P. 1997. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74: 111-122. PMID:9352216.
13. González-Fernández, F., Jiménez, A., López-Blaya, A., Velasco, S., Arriero, M.M., Celdrán, A., et al. 2001. Cerivastatin prevents tumour necrosis factor-alpha-induced downregulation of endothelial nitric oxide synthase: role of endothelial cytosolic proteins. Atherosclerosis, 155: 61-70. doi:10.1016/S0021-9150(00)00535-9. PMID:11223427.
14. Guo, L.J., Luo, X.H., Xie, H., Zhou, H.D., Yuan, L.Q., Wang, M., and Liao, E.Y. 2006. Tissue inhibitor of matrix metalloproteinase-1 suppresses apoptosis of mouse bone marrow stromal cell line MBA-1. Calcif. Tissue Int. 78: 285-292. doi:10.1007/s00223-005-0092-x. PMID:16691494.
15. Hovsepian, D.M., Ziporin, S.J., Sakurai, M.K., Lee, J.K., Curci, J.A., and Thompson, R.W. 2000. Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease. J. Vasc. Interv. Radiol. 11: 1345-1352. doi:10.1016/S1051-0443(07)61315-3. PMID:11099248.
16. Ichihara, S., Noda, A., Nagata, K., Obata, K., Xu, J., Ichihara, G., et al. 2006. Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure. Cardiovasc. Res. 69: 726-735. doi:10.1016/j.cardiores.2005.08.001. PMID:16165109.
17. Lambert, E., Boudot, C., Kadri, Z., Soula-Rothhut, M., Sowa, M.L., Mayeux, P., et al. 2003. Tissue inhibitor of metalloproteinases-1 signalling pathway lead up to erythroid cell survival. Biochem. J. 372: 767-774. doi:10.1042/BJ20030187. PMID:12639219.
18. Liao, J.K. 2002. Beyond lipid lowering: the role of statins in vascular protection. Int. J. Cardiol. 86: 5-18. doi:10.1016/S0167-5273(02)00195-X. PMID:12243846.
19. Lindholt, J.S., Vammen, S., Fasting, H., Henneberg, E.W., and Heickendorff, L. 2000. The plasma level of matrix metalloproteinase may predict the natural history of small abdominal aortic aneurysms. A preliminary study. Eur. J. Vasc. Endovasc. Surg. 20: 281-285. doi:10.1053/ejvs.2000.1151. PMID:10986027.
20. Liu, X.W., Taube, M.E., Jung, K.K., Dong, Z., Lee, Y.J., Roshy, S., et al. 2005. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells from extrusica cell death: a potential oncogenic activity of tissue inhibitor of metalloproteinase-1. Cancer Res. 65: 898-906. PMID:15705888.
21. Longo, G.M., Xiong, W., Greiner, T.C., Zhao, Y., Fiotti, N., and Baxter, B.T. 2002. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J. Clin. Invest. 110: 625-632. PMID:12208863.
22. McMillan, W.D., Patterson, B.K., Keen, R.R., Shively, V.P., Cipollone, M., and Pearce, W.H. 1995. In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in Aneurysmal, occlusive, and normal aorta. Arterioscler. Thromb. Vasc. Biol. 15: 1139-1144. PMID:7627707.
23. Mosorin, M., Niemela, E., Heikkinen, J., Lahtinen, J., Tiozzo, V., Satta, J., et al. 2008. The use of statins and fate of small abdominal aortic aneurysms. Interact. Cardiovasc. Thorac. Surg., Epub ahead of print. PMID:18430763.
24. Nagashima, H., Aoka, Y., Sakomura, Y., Sakuta, A., Aomi, S., Ishizuka, N., et al. 2002. A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. J. Vasc. Surg. 36: 158-163. doi:10.1067/mva.2002. 123680. PMID:12096274.
25. Nomura, S., Yoshimura, K., Akiyama, N., Mikamo, A., Furutani, A., Aoki, H., et al. 2005. HMG-CoA reductase inhibitors reduce matrix metalloproteinase-9 activity in human varicose veins. Eur. Surg. Res. 37: 370-378. doi:10.1159/000090339. PMID:16465063.
26. Petersen, E., Wagberg, F., and Angquist, K.A. 2002. Proteolysis of the abdominal aortic aneurysm wall and the association with rupture. Eur. J. Vasc. Endovasc. Surg. 23: 153-157. doi:10.1053/ejvs.2001.1572. PMID:11863333.
27. Pyo, R., Lee, J.K., Shipley, J.M., Curci, J.A., Mao, D., Ziporin, S.J., et al. 2000. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Invest. 105: 1641-1649. doi:10.1172/JCI8931. PMID:10841523.
28. Rowe, V.L., Stevens, S.L., Reddick, T.T., Freeman, M.B., Donnell, R., Carroll, R.C., et al. 2000. Vascular smooth muscle cell apoptosis in aneurysmal, occlusive, and normal human aortas. J. Vasc. Surg. 31: 567-576. doi:10.1016/S0741-5214(00)90319-7. PMID:10709071.
29. Scandinavian Simvastatin Survival Study Group. 1994. Randomized trial of cholesterol lowering in 4444 patient with coronary heart disease; the Scandinavian Simvastatin Survival Study (4S). Lancet, 344: 1383-1389. PMID:7968073.
30. Steinmetz, E.F., Buckley, C., Shames, M.L., Ennis, T.L., Vanvickle-Chavez, S.J., Mao, D., et al. 2005. Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. Ann. Surg. 241: 92-101. PMID:15621996.
31. Thompson, R.W., Holmes, D.R., Mertens, R.A., Liao, S., Botney, M.D., Mecham, R.P., et al. 1995. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysm. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J. Clin. Invest. 96: 318-326. doi:10.1172/JCI118037. PMID:7615801.
32. Vela-Navarrete, R., Escribano-Burgos, M., Farré, A.L., García-Cardoso, J., Manzarbeitia, F., and Carrasco, C. 2005. Serenoa repente treatment modifies bax/bcl-2 index expression and castrase-3 activity in prostatic tissue from patients with benign prostatic hyperplasia. J. Urol. 173: 507-510. doi:10.1097/01.ju.0000150533.94952.25. PMID:15643230.
33. Wagner, A.H., Köhler, T., Rückschloss, U., Just, I., and Hecker, M. 2000. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler. Thromb. Vasc. Biol. 20: 61-69. PMID:10634801.
34. Watanabe, T., Sato, A., Sawai, T., Uzuki, M., Goto, H., Yamashita, H., et al. 2006. The elevated level of circulating matrix metalloproteinase-9 in patients with abdominal aortic aneurysms decreased to levels equal to those of healthy controls after an aortic repair. Ann. Vasc. Surg. 20: 317-321. doi:10.1007/s10016-006-9038-7. PMID:16779512.
35. Weitz-Schmidt, G. 2002. Statins as anti-inflammatory agents. Trends Pharmacol. Sci. 23: 482-486. doi:10.1016/S0165-6147(02)02077-1. PMID:12368073.
36. Willenbrock, F., and Murphy, G. 1994. Structure-function relationships in the tissue inhibitors of metalloproteinases. Am. J. Respir. Crit. Care Med. 150: S165-S170. PMID:7952654.
37. Wilson, W.R., Evans, J., Bell, P.R., and Thompson, M.M. 2005. HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. 30: 259-262. doi:10.1016/j.ejvs.2005.02.044. PMID:16009575.
38. WOSCOPS Study. 1998. Influence of Pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study. Circulation, 97: 1440-1445. PMID:9576423.
39. Zamzami, N., Brenner, C., Marzo, I., Susin, S.A., and Kroemer, G. 1998. Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene, 16: 2265-2282. doi:10.1038/sj.onc.1201989. PMID:9619836.
40. Zhang, J., Schmidt, J., Ryschich, E., Schumacher, H., and Allenberg, J.R. 2003. Increased apoptosis and decreased density of medial smooth muscle cells in human abdominal aortic aneurysms. Chin. Med. J. (Engl.), 116: 1549-1552. PMID:14570621.